We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Xolair Interventional Study in ASD Patients With Comorbid Atopy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04535817
Recruitment Status : Withdrawn (We are terminating due to loss of funding because of Covid-19.)
First Posted : September 2, 2020
Last Update Posted : August 18, 2021
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Xue-Jun Kong, Beth Israel Deaconess Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : January 1, 2022
Estimated Study Completion Date : January 1, 2022